Anvisa warns of illegal sales of unapproved weight-loss drug retraglutide

Brazil's health regulator, Anvisa, has issued a warning regarding the illicit sale of products labeled as 'retraglutide,' noting that the drug has not received regulatory approval for commercial distribution anywhere globally. The agency's alert highlights the risks of consuming unverified pharmaceutical compounds currently circulating in the black market.